Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -31.614% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) COC(=O)c1ccc(CSc2nnc3ccccn23)o1
b.) CCOC(=O)/C=C/CN(C(=O)OC(C)(C)C)S(=O)(=O)N1CC=CC1
c.) Cc1c(-c2ccccc2)[n+](=O)c2c(n1[O-])CCCC2
d.) CC(C)c1ccc(C2=NN(c3ccccc3)C(=O)CC2)cc1
Answer: d. CC(C)c1ccc(C2=NN(c3ccccc3)C(=O)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)c1ccc(C2=NN(c3ccccc3)C(=O)CC2)cc1
CC(C)c1ccc(C2=NN(c3ccccc3)C(=O)CC2)cc1
2-phenyl-6-(4-propan-2-ylphenyl)-4,5-dihydropyridazin-3-one